1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
  1. My Preqin
Book a demo

Westlake Omics

Have updates for this profile?  Please contribute data

About
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2020

Location

Hangzhou Zhejiang China

Primary Industry

Biotechnology

About

Established in 2020 and based in Hangzhou, China, Westlake Omics operates as a proteome diagnostic service provider that provides auxiliary clinical diagnosis method. The company cooperates with Sciex, Thermo Fisher and Pressure BioSciences Inc. The company provides auxiliary clinical diagnosis method for patients with major human diseases such as tumor. The company adopts proteome big data and artificial intelligence technology. The company will put the funding towards product R&D.
Current Investors
Gaorong Ventures, CD Capital, GL Ventures

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Healthcare
Verticals
Artificial Intelligence, Big Data
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo